Literature DB >> 637625

delta9-Tetrahydrocannabinol: tolerance after noncontingent exposure in rats.

T U Järbe.   

Abstract

Rats pretreated daily with delta9-tetrahydrocannabinol (delta9-THC, 8 mg/kg) during 14 days showed tolerance to THC-induced hypothermia and depression of CAR acquisition in a shuttle-box. The noncontingent exposure of THC also produced tolerance to spontaneous (unlearned) behaviors as measured in a open-field test. The data suggest no essential role for learned tolerance in the sense that animals have to to learn to perform under the influence of THC for several of these behaviors.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 637625

Source DB:  PubMed          Journal:  Arch Int Pharmacodyn Ther        ISSN: 0003-9780


  4 in total

1.  AM2389, a high-affinity, in vivo potent CB1-receptor-selective cannabinergic ligand as evidenced by drug discrimination in rats and hypothermia testing in mice.

Authors:  Torbjörn U C Järbe; Sherrica Tai; Brian J LeMay; Spyros P Nikas; Vidyanand G Shukla; Alexander Zvonok; Alexandros Makriyannis
Journal:  Psychopharmacology (Berl)       Date:  2011-10-12       Impact factor: 4.530

2.  Cannabinoid withdrawal in mice: inverse agonist vs neutral antagonist.

Authors:  Sherrica Tai; Spyros P Nikas; Vidyanand G Shukla; Kiran Vemuri; Alexandros Makriyannis; Torbjörn U C Järbe
Journal:  Psychopharmacology (Berl)       Date:  2015-03-15       Impact factor: 4.530

3.  Tolerance to hypothermic and antinoceptive effects of ∆9-tetrahydrocannabinol (THC) vapor inhalation in rats.

Authors:  Jacques D Nguyen; Yanabel Grant; Tony M Kerr; Arnold Gutierrez; Maury Cole; Michael A Taffe
Journal:  Pharmacol Biochem Behav       Date:  2018-07-19       Impact factor: 3.533

4.  Blood levels do not predict behavioral or physiological effects of Δ⁹-tetrahydrocannabinol in rhesus monkeys with different patterns of exposure.

Authors:  Brett C Ginsburg; Lenka Hruba; Armia Zaki; Martin A Javors; Lance R McMahon
Journal:  Drug Alcohol Depend       Date:  2014-03-19       Impact factor: 4.492

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.